Dravet Syndrome

Also known as: Severe myoclonic epilepsy of infancy / Epilepsy, Myoclonic, Infantile, Severe

DrugDrug NameDrug Description
DB00574FenfluramineFenfluramine is a phenethylamine that is structurally similar to serotonin. Due to its ability to increase extracellular serotonin levels, modulate serotonergic and other neurologic receptors, and control neurotransmission, it is effective in treating pharmacoresistant seizures.
DB09118StiripentolAn anticonvulsant agent used with clobazam and valproate as an adjunct to treat refractory generalized tonic-clonic seizures in Dravet syndrome.
DrugDrug NamePhaseStatusCount
DB09061Cannabidiol1 / 2Terminated1
DB00574Fenfluramine1 / 2Active Not Recruiting1
DB09061Cannabidiol2Completed1
DB00661Verapamil2Completed1
DB09061Cannabidiol3Completed3
DB09061Cannabidiol3Recruiting1
DB09061Cannabidiol3Withdrawn1
DB00349Clobazam3Terminated1
DB00349Clobazam3Withdrawn1
DB00574Fenfluramine3Active Not Recruiting1
DB00574Fenfluramine3Completed1
DB00574Fenfluramine3Enrolling by Invitation3
DB00574Fenfluramine3Recruiting1
DB00574FenfluramineNot AvailableAvailable2
DB09118StiripentolNot AvailableApproved for Marketing1
DB09118StiripentolNot AvailableNo Longer Available3